Live Breaking News & Updates on New Amsterdam Pharma

Stay updated with breaking news from New amsterdam pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Daniel Gaudet, MD, PhD: Contextualizing Plozasiran Data from SHASTA-2, Upcoming MUIR Data

Daniel Gaudet, MD, PhD, discusses SHASTA-2 data and what cardiologists could learn from the forthcoming 48-week MUIR trial data from EAS 2024. ....

Daniel Gaudet , Eli Lilly , Boehringer Ingelheim , American College Of Cardiology , Novo Nordisk , Arrowhead Pharmaceuticals , American College , Annual Scientific Session , Arrowhead Pharmaceutical , New Amsterdam Pharma ,

NanoPhoria appoints Dr. Suman Shirodkar as Chair and Prof. Michael Davidson as Non-Executive Member of the Board of Directors

NanoPhoria appoints Dr. Suman Shirodkar as Chair and Prof. Michael Davidson as Non-Executive Member of the Board of Directors
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Lucia Faccio , Michaelh Davidson , Suman Shirodkar , Cambridge Epigenetix , Medicines Company , Bristol Myers Squibb , Omthera Pharmaceuticals , University Of Chicago , Mckinsey Co , Michael Davidson , Non Executive Member , Larkspur Biosciences , Lipid Clinic , Sofinnova Partners , Chief Executive Officer , New Amsterdam Pharma , Chief Executive ,

Tracking Ole Andreas Halvorsen's Viking Global Portfolio – Q3 2023 Update

Tracking Ole Andreas Halvorsen's Viking Global Portfolio – Q3 2023 Update
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Amylyx Pharma , Sherwin Williams , Julian Robertson , Biomarin Pharma , Andreas Halvorsen , Scott Olson , John Vincent , Lululemon Athletica , Bridgebio Pharma , Guardant Health , Roivant Sciences , International Flavors , Arista Networks , Danaher Corp , Allan And Co Gathering In Sun Valley , Progressive Corp , Block Inc , Api Group , Visa Inc , Metlife Inc , Rallybio Corp , Micron Technology , Microsoft Corporation , Elevance Health , Fortinet Inc , Chubb Ltd ,

New PCSK9 Inhibitor Allows 3-Month Treatment Intervals

"It s a new antibody that has a long half-life so each treatment can be prolonged." ....

United States , South Australia , Eli Lilly , Stephen Nicholls , Victorian Heart Institute , Capital Medical University , American Heart Association , Medicines Company , Boehringer Ingelheim , Monash University , Add On Therapy , Patients With Non Familial Hypercholesterolemia , Mixed Hyperlipidemia , Beijing Anzhen Hospital , American Heart , New Amsterdam Pharma , Ipid Management , Roprotein Convertase Subtilisin Kexin Type 9 , Cardiometabolic Risk , Low Ldl Cholesterol , Ow Low Density Lipoprotein Cholesterol , Familial Hypercholesterolemia , Upper Respiratory Infection , Nt Ears , Cardiovascular Disease , Vd Card ,

Muvalaplin and Olpasiran Show Promise in Lowering Lp(a)

Oral muvalaplin lowered lipoprotein(a) in a phase 1 study, and injectable olpasiran did so in an extension of a phase 2 study, both with no adverse safety signals, researchers report. ....

United States , Noord Holland , United Kingdom , South Australia , Eli Lilly , Louise Bowman , Michellel Odonoghue , Stephenj Nicholls , University Of Oxford , European Society Of Cardiology , Harvard Medical School , Medicines Company , American Heart Association Scientific Sessions , Monash University , Victoria Heart Institute , Boehringer Ingelheim , European Society , New England Journal , New Amsterdam Pharma , Ipid Management , Roprotein Convertase Subtilisin Kexin Type 9 , Low Ldl Cholesterol , Ow Low Density Lipoprotein Cholesterol , Body Mass Index Bmi , Cardiovascular Disease , Vd Cardiovascular Disease ,